Platelet activity and cardiovascular risk in apparently healthy individuals: A review of the data

Journal of Thrombosis and Thrombolysis

Volumn 32, Issue 2, 2011, Pages 201-208

  Sharma, Gaurav ^a   Berger, Jeffrey S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular risk factor; Mean platelet volume; Platelet activity; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; BETA THROMBOGLOBULIN; BIOLOGICAL MARKER; CD40 LIGAND; COLLAGEN; PADGEM PROTEIN; THROMBIN; THROMBOCYTE FACTOR 4; THROMBOXANE; THROMBOXANE A2;

AGE DISTRIBUTION; ANALYTIC METHOD; ARTERIAL WALL THICKNESS; ATHEROGENESIS; ATHEROSCLEROSIS; BLEEDING TIME; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ACTIVITY; CELL INTERACTION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG URINE LEVEL; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; FATTY ACID SYNTHESIS; FOLLOW UP; HEART INFARCTION; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IN VIVO STUDY; INCIDENCE; ISCHEMIC HEART DISEASE; MORTALITY; NONHUMAN; OBESITY; OPTICAL DENSITY; PLATELET AGGREGOMETRY; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX RATIO; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; THROMBOCYTE VOLUME; TURBIDIMETRY; VENOUS THROMBOEMBOLISM;

BLEEDING TIME; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CD40 LIGAND; FEMALE; HUMANS; MALE; P-SELECTIN; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; RISK FACTORS;

EID: 80052511874     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0590-9     Document Type: Review

References (63)

1. Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS (2010) Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 55:1169-1177
2. Davi G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357:2482-2494
3. Vorchheimer DA, Becker R (2006) Platelets in atherothrombosis. Mayo Clin Proc 81:59-68 (Pubitemid 43054319)
4. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS (2010) Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8:148-156
5. Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD (2007) Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol 50:1822-1834 (Pubitemid 350007957)
6. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348:1104-1111 (Pubitemid 36337321)
7. Trip MD, Cats VM, van Capelle FJ, Vreeken J (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322:1549-1554 (Pubitemid 20176694)
8. Elwood PC, Beswick A, Pickering J, McCarron P, O'Brien JR, Renaud SR, Flower RJ (2001) Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the caerphilly prospective study. Br J Haematol 113:514-520 (Pubitemid 32523163)
9. Sharp DS, Bath PMW, Martin JF, Beswick AD, Sweetnam PM (1994) Platelet and erythrocyte volume and count: epidemiological predictors of impedance measured adp-induced platelet aggregation in whole blood. Platelets 5:6
10. Breddin HK (2005) Can platelet aggregometry be standardized? Platelets 16:151-158
11. Sharp DS, Beswick AD, O'Brien JR, Renaud S, Yarnell JW, Elwood PC (1990) The association of platelet and red cell count with platelet impedance changes in whole blood and light-scattering changes in platelet rich plasma: evidence from the caerphilly collaborative heart disease study. Thromb Haemost 64:211-215 (Pubitemid 20351867)
12. Yee DL, Sun CW, Bergeron AL, Dong JF, Bray PF (2005) Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 106:2723-2729 (Pubitemid 41510746)
13. Yee DL, Bergeron AL, Sun CW, Dong JF, Bray PF (2006) Platelet hyperreactivity generalizes to multiple forms of stimulation. J Thromb Haemost 4:2043-2050 (Pubitemid 44226787)
14. Breddin HK, Lippold R, Bittner M, Kirchmaier CM, Krzywanek HJ, Michaelis J (1999) Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteers. Atherosclerosis 144:211-219 (Pubitemid 29259982)
15. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84:613-617
16. Meade TW, Cooper JA, Miller GJ (1997) Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD). Thromb Haemost 78:926-929 (Pubitemid 27365594)
17. Elwood PC, Renaud S, Beswick AD, O'Brien JR, Sweetnam PM (1998) Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort. Heart 80:578-582 (Pubitemid 28561692)
18. Sharp DS, Ben-Shlomo Y, Beswick AD, Andrew ME, Elwood PC (2005) Platelet aggregation in whole blood is a paradoxical predictor of ischaemic stroke: Caerphilly Prospective Study revisited. Platelets 16:320-328 (Pubitemid 41491700)
19. van der Loo B, Martin JF (1999) A role for changes in platelet production in the cause of acute coronary syndromes. Arterioscler Thromb Vasc Biol 19:672-679 (Pubitemid 29135170)
20. Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7:157-161 (Pubitemid 26167943)
21. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399-404 (Pubitemid 34451156)
22. Senaran H, Ileri M, Altinbas A, Kosar A, Yetkin E, Ozturk M, Karaaslan Y, Kirazli S (2001) Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol 24:405-408 (Pubitemid 32391202)
23. Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, Hansen JB (2010) Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway. J Thromb Haemost 8:157-162
24. Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG (2010). High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost
25. Buckley MF, James JW, Brown DE, Whyte GS, Dean MG, Chesterman CN, Donald JA (2000) A novel approach to the assessment of variations in the human platelet count. Thromb Haemost 83:480-484 (Pubitemid 30148365)
26. Pizzi C, De Stavola BL, Meade TW (2010) Long-term association of routine blood count (Coulter) variables on fatal coronary heart disease: 30 year results from the first prospective Northwick Park Heart Study (NPHS-I). Int J Epidemiol 39:256-265
27. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96:1102-1108 (Pubitemid 27344210)
28. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK (1999) Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100:736-742 (Pubitemid 29383644)
29. van der Bom JG, Heckbert SR, Lumley T, Holmes CE, Cushman M, Folsom AR, Rosendaal FR, Psaty BM (2009) Platelet count and the risk for thrombosis and death in the elderly. J Thromb Haemost 7:399-405
30. Michelson AD, Frelinger AL 3rd, Furman MI (2006) Current options in platelet function testing. Am J Cardiol 98:4N-10N
31. Rodgers RP, Levin J (1990) A critical reappraisal of the bleeding time. Semin Thromb Hemost 16:1-20 (Pubitemid 20049639)
32. Milner PC, Martin JF (1985) Shortened bleeding time in acute myocardial infarction and its relation to platelet mass. Br Med J (Clin Res Ed) 290:1767-1770 (Pubitemid 15059204)
33. O'Brien JR, Jamieson S, Etherington M, Klaber MR, Ainsworth JF (1973) Stressed template bleeding-time and other plateletfunction tests in myocardial infarction. Lancet 1:694-696
34. Elwood PC, Pickering J, Yarnell J, O'Brien JR, Ben Shlomo Y, Bath P (2003) Bleeding time, stroke and myocardial infarction: the Caerphilly prospective study. Platelets 14:139-141 (Pubitemid 36609805)
35. Johnson-Tidey RR, McGregor JL, Taylor PR, Poston RN (1994) Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol 144:952-961 (Pubitemid 24160636)
36. Ridker PM, Buring JE, Rifai N (2001) Soluble P-selectin and the risk of future cardiovascular events. Circulation 103:491-495 (Pubitemid 32116231)
37. Cleanthis M, Smout J, Bhattacharya V, Ashour H, Dyker A, Ford GA, Mikhailidis DP, Stansby GP (2008) Soluble but not platelet P-selectin correlates with spontaneous platelet aggregation: a pilot study. Clin Appl Thromb Hemost 14:227-233 (Pubitemid 351364017)
38. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, Sugi K, Imaizumi T (1995) Increased soluble form of P-selectin in patients with unstable angina. Circulation 92:1693-1696
39. Sakurai S, Inoue A, Koh CS, Owa M, Yanagisawa N (1997) Soluble form of selectins in blood of patients with acute myocardial infarction and coronary intervention. Vasc Med 2:163-168 (Pubitemid 27468147)
40. Blann AD, Nadar SK, Lip GY (2003) The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24:2166-2179 (Pubitemid 37522669)
41. Reiner AP, Carlson CS, Thyagarajan B, Rieder MJ, Polak JF, Siscovick DS, Nickerson DA, Jacobs DR Jr, Gross MD (2008) Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 28:1549-1555
42. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A, Haskard D (2001) Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 358:971-976
43. Schonbeck U, Varo N, Libby P, Buring J, Ridker PM (2001) Soluble CD40L and cardiovascular risk in women. Circulation 104:2266-2268 (Pubitemid 33049505)
44. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594 (Pubitemid 28157601)
45. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD (2002) CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism. Nat Med 8:247-252 (Pubitemid 34250102)
46. Prasad KS, Andre P, He M, Bao M, Manganello J, Phillips DR (2003) Soluble CD40 ligand induces β3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. P roc Natl Acad Sci USA 100:12367-12371 (Pubitemid 37271566)
47. Riondino S, Martini F, La Farina F, Spila A, Guadagni F, Ferroni P (2010) Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions. Clin Biochem 43:666-670
48. Vishnevetsky D, Kiyanista VA, Gandhi PJ (2004) CD40 ligand: a novel target in the fight against cardiovascular disease. Ann Pharmacother 38:1500-1508 (Pubitemid 39100206)
49. Ferro D, Loffredo L, Polimeni L, Fimognari F, Villari P, Pignatelli P, Fuster V, Violi F (2007) Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler Thromb Vasc Biol 27:2763-2768 (Pubitemid 350158934)
50. Novo S, Basili S, Tantillo R, Falco A, Davi V, Novo G, Corrado E, Davi G (2005) Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. Stroke 36:673-675 (Pubitemid 40344177)
51. Smyth EM (2010) Thromboxane and the thromboxane receptor in cardiovascular disease. Clin Lipidol 5:209-219
52. Vejar M, Fragasso G, Hackett D, Lipkin DP, Maseri A, Born GV, Ciabattoni G, Patrono C (1990) Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb Haemost 63:163-168 (Pubitemid 20128175)
53. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA (1986) Platelet activation in unstable coronary disease. N Engl J Med 315: 983-989 (Pubitemid 16028578)
54. Thachil J (2010) The prothrombotic potential of platelet factor 4. Eur J Intern Med 21:79-83
55. Nassar T, Sachais BS, Akkawi S, Kowalska MA, Bdeir K, Leitersdorf E, Hiss E, Ziporen L, Aviram M, Cines D, Poncz M, Higazi AA (2003) Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 278:6187-6193 (Pubitemid 36800873)
56. Weber C (2005) Platelets and chemokines in atherosclerosis: partners in crime. Circ Res 96:612-616 (Pubitemid 40478327)
57. Nichols AB, Owen J, Kaplan KL, Sciacca RR, Cannon PJ, Nossel HL, Fibrinopeptide A (1982) Platelet factor 4, and beta-thromboglobulin levels in coronary heart disease. Blood 60:650-654 (Pubitemid 12027142)
58. Kutti J, Svardsudd K, Sigvaldason A, Safai-Kutti S, Wadenvik H (1983) Plasma platelet factor 4: a potentially useful predictor of ischaemic heart disease? Folia Haematol Int Mag Klin Morphol Blutforsch 110:868-873
59. van Hulsteijn H, Kolff J, Briet E, van der Laarse A, Bertina R (1984) Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction. Am Heart J 107:39-45 (Pubitemid 14219163)
60. Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA (1981) Studies of human plate alpha-granule release in vivo. Blood 58:607-618 (Pubitemid 11002766)
61. Caimi G, Hoffmann E, Montana M, Incalcaterra E, Dispensa F, D'Amico T, Canino B, Lo Presti R (2005) Plasma markers of platelet and polymorphonuclear leukocyte activation in young adults with acute myocardial infarction. Clin Hemorheol Microcirc 32:67-74 (Pubitemid 40164162)
62. Snoep JD, Roest M, Barendrecht AD, de Groot PG, Rosendaal FR, van der Bom JG (2010) High platelet reactivity is associated with myocardial infarction in premenopausal women: a population- based case-control study. J Thromb Haemost 8(5):906-913
63. Smith C, Damas JK, Otterdal K, Oie E, Sandberg WJ, Yndestad A, Waehre T, Scholz H, Endresen K, Olofsson PS, Halvorsen B, Gullestad L, Froland SS, Hansson GK, Aukrust P (2006) Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation. J Am Coll Cardiol 48:1591-1599 (Pubitemid 44528185)